Sumitomo Pharma America, Inc.

NCT06650579

CollaboratorPhase 3Recruiting202572 people21 Oct 2024clinicaltrials.gov

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

CollaboratorNo phaseRecruiting2023100 people30 May 2023clinicaltrials.gov

NCT02483247

Phase 1Completed2015165 people26 Jun 2015clinicaltrials.gov

NCT02352558

Phase 1Completed201515 people2 Feb 2015clinicaltrials.gov

NCT02279719

Phase 1/2Completed201497 people31 Oct 2014clinicaltrials.gov

NCT01033825

Phase 3Completed2010310 people17 Dec 2009clinicaltrials.gov

NCT00988429

CollaboratorPhase 3Completed2008653 people2 Oct 2009clinicaltrials.gov

NCT00615433

Phase 3Completed2008478 people14 Feb 2008clinicaltrials.gov

NCT00511134

CollaboratorPhase 4Terminated20074 people3 Aug 2007clinicaltrials.gov